The outcome of IVF/ICSI cycles in male cancer patients: retrospective analysis of procedures from 2004 to 2018.


Journal

Radiology and oncology
ISSN: 1581-3207
Titre abrégé: Radiol Oncol
Pays: Poland
ID NLM: 9317213

Informations de publication

Date de publication:
05 03 2021
Historique:
received: 18 08 2020
accepted: 25 01 2021
pubmed: 7 3 2021
medline: 16 9 2021
entrez: 6 3 2021
Statut: epublish

Résumé

Fertility preservation is an important aspect of quality of life in oncological patients, and in men is achieved by semen cryopreservation prior to treatment. Results of We performed a retrospective analysis of IVF/intracytoplasmic sperm injection (IVF/ICSI) procedures in infertile couples where men had been treated for cancer in the past. We additionally compared the results of IVF/ICSI procedures with respect to the type of semen used (fresh, cryopreserved). We compared the success rates of 214 IVF/ICSI cycles performed in the years 2004-2018. Pregnancy (30.0% The success of IVF/ICSI procedures in couples where the male partner was treated for cancer in the past are the same in terms of pregnancies and live-births in fresh cycles regardless of the type of semen used. However, embryo utilization and embryo cryopreservation rates are significantly higher when cryopreserved semen is used, leading to a significantly higher cumulative number of couples who achieved at least one pregnancy.

Identifiants

pubmed: 33675201
pii: raon-2021-0011
doi: 10.2478/raon-2021-0011
pmc: PMC8042825
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

221-228

Informations de copyright

© 2021 Tanja Burnik Papler, Eda Vrtacnik-Bokal, Saso Drobnic, Martin Stimpfel, published by Sciendo.

Références

Hum Reprod Update. 2001 Jul-Aug;7(4):370-7
pubmed: 11476349
Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Sep;14(3):453-71
pubmed: 11097786
Fertil Steril. 2013 Dec;100(6):1555-63.e1-3
pubmed: 24034937
Asian J Androl. 2013 May;15(3):382-6
pubmed: 23524529
Hum Reprod Update. 2001 Jul-Aug;7(4):363-9
pubmed: 11476348
Andrologia. 2019 Jul;51(6):e13263
pubmed: 30838696
Reprod Biomed Online. 2017 Nov;35(5):494-510
pubmed: 28784335
Basic Clin Androl. 2016 Feb 18;26:3
pubmed: 26893905
Investig Clin Urol. 2018 May;59(3):177-181
pubmed: 29744474
Reprod Biomed Online. 2015 Feb;30(2):120-7
pubmed: 25530036
Hum Reprod Update. 2004 Nov-Dec;10(6):525-32
pubmed: 15319377
Fertil Steril. 2000 Jun;73(6):1155-8
pubmed: 10856474
Science. 2019 Mar 22;363(6433):1314-1319
pubmed: 30898927
Andrologia. 2009 Dec;41(6):377-82
pubmed: 19891636
J Pediatr Oncol Nurs. 2006 Jul-Aug;23(4):182-8
pubmed: 16766683
PLoS One. 2013 Dec 05;8(12):e82249
pubmed: 24349236
Hum Reprod Open. 2020 Jul 31;2020(3):hoaa032
pubmed: 32760812
J Assist Reprod Genet. 2017 Jun;34(6):733-740
pubmed: 28455755
Fertil Steril. 2008 Dec;90(6):2245-50
pubmed: 18191846
Cancer. 2007 Sep 1;110(5):1125-9
pubmed: 17647219
Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):177-82
pubmed: 23870186
Eur Urol. 2007 Aug;52(2):355-67
pubmed: 17498866
Fertil Steril. 2008 Sep;90(3):557-63
pubmed: 18692822
Fertil Steril. 2004 Feb;81(2):342-8
pubmed: 14967371
Fertil Steril. 2006 Mar;85(3):640-5
pubmed: 16500332
Nature. 2002 Aug 15;418(6899):778-81
pubmed: 12181567
Cancer. 2003 Apr 1;97(7):1624-9
pubmed: 12655518
Ann Oncol. 2019 Apr 1;30(4):604-611
pubmed: 30798330
Ther Adv Med Oncol. 2016 Nov;8(6):412-420
pubmed: 27800030
Lancet. 2014 Oct 4;384(9950):1295-301
pubmed: 25283570
Anticancer Agents Med Chem. 2010 Jan;10(1):92-102
pubmed: 19912104
Hum Reprod. 2010 Aug;25(8):1877-83
pubmed: 20551071
Fertil Steril. 1989 Apr;51(4):661-4
pubmed: 2924933
Hum Reprod. 2001 Dec;16(12):2632-9
pubmed: 11726587
J Assist Reprod Genet. 2016 Mar;33(3):325-333
pubmed: 26678493
Fertil Steril. 2013 Nov;100(5):1180-6
pubmed: 24012199
Reproduction. 2009 Aug;138(2):187-94
pubmed: 19372227
Reprod Fertil Dev. 2017 Apr;29(4):637-645
pubmed: 26464079
Asian J Androl. 2013 May;15(3):425-9
pubmed: 23542137
Reprod Biomed Online. 2016 Feb;32(2):147-53
pubmed: 26687904
J Clin Oncol. 2013 Jul 1;31(19):2500-10
pubmed: 23715580

Auteurs

Tanja Burnik Papler (TB)

Department of Human Reproduction, Division of Gynaecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Eda Vrtacnik-Bokal (E)

Department of Human Reproduction, Division of Gynaecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Saso Drobnic (S)

Department of Human Reproduction, Division of Gynaecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Martin Stimpfel (M)

Department of Human Reproduction, Division of Gynaecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH